Recombinant hepatitis B vaccine(CHO Cell) (Beijing Waldron Biotechnology)

重组乙型肝炎疫苗（CHO细胞）（北京华尔盾生物技术有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant hepatitis B vaccine(CHO Cell) (Beijing Waldron Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesBeijing Waldron Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Waldron Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A